Department of Preventive Medicine, Keck School of Medicine of University of Southern California, Los Angeles, California.
Center for Genetic Epidemiology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2686-2692. doi: 10.1158/1055-9965.EPI-20-0963. Epub 2020 Sep 21.
Genome-wide association studies (GWAS) have identified several SNPs associated with pancreatic cancer. No studies yet have attempted to replicate these SNPs in US minority populations. We aimed to replicate the associations of 31 GWAS-identified SNPs with pancreatic cancer and build and test a polygenic risk score (PRS) for pancreatic cancer in an ethnically diverse population.
We evaluated 31 risk variants in the Multiethnic Cohort and the Southern Community Cohort Study. We included 691 pancreatic ductal adenocarcinoma (PDAC) cases and 13,778 controls from African-American, Japanese-American, Latino, Native Hawaiian, and white participants. We tested the association between each SNP and PDAC, established a PRS using the 31 SNPs, and tested the association between the score and PDAC risk.
Eleven of the 31 SNPs were replicated in the multiethnic sample. The PRS was associated with PDAC risk [OR top vs. middle quintile = 2.25 (95% confidence interval, 1.73-2.92)]. Notably, the PRS was associated with PDAC risk in all ethnic groups except Native Hawaiian (OR per risk allele ranged from 1.33 in Native Hawaiians to 1.91 in African Americans; heterogeneity = 0.12).
This is the first study to replicate 11 of the 31 GWAS-identified risk variants for pancreatic cancer in multiethnic populations, including African Americans, Japanese Americans, and Latinos. Our results also suggest a potential utility of PRS with GWAS-identified risk variants for the identification of individuals at increased risk for PDAC across multiple ethnic groups.
PRS can potentially be used to stratify pancreatic cancer risk across multiple ethnic groups.
全基因组关联研究(GWAS)已经确定了几个与胰腺癌相关的 SNP。目前还没有研究试图在美籍少数族裔群体中复制这些 SNP。我们的目的是在一个种族多样化的人群中复制 31 个 GWAS 确定的 SNP 与胰腺癌的关联,并构建和测试胰腺癌的多基因风险评分(PRS)。
我们评估了多民族队列和南方社区队列研究中的 31 个风险变异。我们纳入了 691 例胰腺导管腺癌(PDAC)病例和 13778 例来自非裔美国人、日裔美国人、拉丁裔、夏威夷原住民和白人参与者的对照。我们测试了每个 SNP 与 PDAC 之间的关联,使用 31 个 SNP 建立了 PRS,并测试了评分与 PDAC 风险之间的关联。
在多民族样本中,有 11 个 SNP 得到了复制。PRS 与 PDAC 风险相关[最高与中间五分位比=2.25(95%置信区间,1.73-2.92)]。值得注意的是,PRS 与除夏威夷原住民以外的所有族裔的 PDAC 风险相关(每个风险等位基因的 OR 范围从夏威夷原住民的 1.33 到非裔美国人的 1.91;异质性=0.12)。
这是第一项在多民族人群中复制 31 个 GWAS 确定的胰腺癌风险变异中的 11 个的研究,包括非裔美国人、日裔美国人和拉丁裔。我们的结果还表明,PRS 与 GWAS 确定的风险变异在多个族裔群体中识别 PDAC 风险增加的个体具有潜在的应用价值。
PRS 可以潜在地用于在多个族裔群体中分层 PDAC 风险。